🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
This is a phase ll study of participants with untreated diffuse large B Cel...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-01-24
Trial ID
NCT06050694
Treatments Being Tested
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
Start Date
2026-03-01
Trial ID
NCT07680933
Treatments Being Tested
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2026-05-06
Trial ID
NCT07594899
This is a prospective, observational, multicenter, cohort study with 400 ne...
Status
Recruiting
Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Start Date
2025-01-01
Trial ID
NCT06779435
Treatments Being Tested
This trial is to evaluate if dexrazoxane is safer and more effective than l...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-08-31
Trial ID
NCT07654426
This is a prospective, multicenter, multi-cohort study of ctDNA combined wi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-05-09
Trial ID
NCT07070648
Treatments Being Tested
Evaluate the efficacy and safety of C Pola R-CHP+X compared to CR-CHOP in t...
Status
Not Yet Recruiting
Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, Shanghai, Shanghai
Start Date
2026-03-31
Trial ID
NCT07511114
Treatments Being Tested
Assess the preliminary efficacy and safety of orelabrutinib in combination ...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-05-05
Trial ID
NCT07078500
Treatments Being Tested
This is an observational, multicenter, prospective cohort study including p...
Status
Not Yet Recruiting
Location
Clinica di Ematologia, AOU Ospedali Riuniti
Start Date
2026-09
Trial ID
NCT07652476
Treatments Being Tested